Genocea Biosciences reported $2.95M in Loan Capital for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Agenus AGEN:US $ 0M 12.82M
Baxter International BAX:US $ 16765M 384M
Bluebird Bio BLUE:US $ 0M 0M
Cytokinetics CYTK:US $ 197.08M 54.24M
Cytori Therapeutics CYTX:US $ 4.72M 287K
Genocea Biosciences GNCA:US $ 2.95M 1.2M
Glaxosmithkline GSK:US $ 29226M 8654M
Infinity Pharmaceuticals INFI:US $ 0M 0M
Merk MRK:US $ 30586M 104M
Mirati Therapeutics MRTX:US $ 0M 0M
Moderna Inc MRNA:US $ 646M 47M
Novavax NVAX:US $ 0M 323.46M
Pfizer PFE:US $ 35656M 539M
Prothena PRTA:US 0 0